http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110174518-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1748dfa19d3cf0e5e93030fc44893f6c |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54306 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-80 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
filingDate | 2019-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b92ca1600131395b9c7be7b523a03e14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea65961e3ab7a87de025443c2bbc0754 |
publicationDate | 2019-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110174518-A |
titleOfInvention | A kind of red blood cell blood group irregular antibody detection kit based on solid phase agglutination technology and preparation method |
abstract | The invention relates to a sorting-type red blood cell blood group irregular antibody detection kit based on solid-phase agglutination technology and a preparation method, and belongs to the technical field of kit preparation. The kit comprises: (1) sorting-type solid-phase agglutination reaction microplate (2) Low ionic strength solution; (3) Indicator system; (4) Negative control serum; (5) Positive control serum; the preparation method includes: (1) preparation of sub-assay solid phase agglutination reaction microplate; (2) ) Preparation of low ionic strength solution; (3) Preparation of indicator system; (4) Preparation of negative control serum; (5) Preparation of positive control serum; The freeze-drying preservation technology and the high-sensitivity two-step indicator system can effectively solve the problems of low sensitivity, difficult to preserve red blood cells, and easy to miss detection in the current clinical irregular antibody detection methods, and provide a cost-effective detection for clinical first-line detection work. Reagent test kit. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113092793-A |
priorityDate | 2019-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 159.